Fredun Pharmaceuticals share news, announcements and annual reports
NSE: FREDUNBSE: 539730Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 2 Nov 2026. Previous close ₹1,367.00.
2 Nov: open ₹1,360.00, high ₹1,420.00, low ₹1,350.10
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹2,380 Cr1,474th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 8.56
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.02%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 18.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.80
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 58,78644.2% delivered
Fredun Pharmaceuticals share news and announcements
665 announcements, routine notices left out, newest first. Page 4 of 14.
Apr 2025
Mar 2025
Feb 2025
Jan 2025
22 Jan · Board meeting
Meeting on 4 Feb 2025: quarterly results9 Jan · Business
Nov 2024
27 Nov · Business
Oct 2024
26 Oct · Board meeting
15 Oct · Board meeting
Meeting on 26 Oct 2024: quarterly results3 Oct · Business
3 Oct · Announcement under Regulation 30 (LODR)-Raising of Funds
3 Oct · Announcement under Regulation 30 (LODR)-Issue of Securities
Sep 2024
26 Sep · Board meeting
Meeting on 3 Oct 20246 Sep · Dividend
6 Sep · Meeting
Jul 2024
29 Jul · Board meeting
22 Jul · Board meeting
Meeting on 29 Jul 2024: quarterly results
May 2024
10 May · Dividend
10 May · Results
10 May · Board meeting
7 May · Business
7 May · Dividend
7 May · Board meeting
Apr 2024
29 Apr · Yearly Certificate Under Reg 40(9) Of LODR Reg, 2015
24 Apr · Board meeting
Meeting on 7 May 2024: audited results and final dividend15 Apr · Board meeting
Meeting on 15 Apr 2024
Mar 2024
22 Mar · Board meeting
Meeting on 22 Mar 2024: preferential issue of shares